Evidence map›Paper›PMID 22118263›Full record

ArticleBMC complementary and alternative medicine2011

Characterization of Salvia miltiorrhiza ethanol extract as an anti-osteoporotic agent.

Yan Cui, Bidur Bhandary, Anu Marahatta, Geum-Hwa Lee, Bo Li, Do-Sung Kim, Soo-Wan Chae, Hyung-Ryong Kim, Han-Jung Chae

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pharmacological effects ofFrontiers in pharmacology · 2026
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Effects ofJournal of dental sciences · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yan CuiDepartment of Pharmacology, Chonbuk National University, Jeonju, Chonbuk, South Korea.
Bidur Bhandary
Anu Marahatta
Geum-Hwa Lee
Bo Li
Do-Sung Kim
Soo-Wan Chae
Hyung-Ryong Kim
Han-Jung Chae
Jeonbuk National University · KRWonkwang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSalvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects. This study was conducted to examine the SM-induced anti-osteoporotic effect and its possible mechanisms with various doses of SM.

methodsWe studied Sprague-Dawley female rats aged 12 weeks, divided into six groups: sham-operated control (SHAM), OVX rats supplemented with SM (1, 3, 10 and 30 mg/kg) orally for 8 weeks. At the end of the experiment, blood samples were collected and biochemistry analysis was performed. Specimens from both tibia and liver were processed for light microscopic examination. DEXA and μ-CT analyses of the tibia were also performed.

resultsSM treatment significantly ameliorated the decrease in BMD and trabecular bone mass according to DEXA and trabecular bone architecture analysis of trabecular bone structural parameters by μ-CT scanning. In serum biochemical analysis, SM decreased the released TRAP-5b, an osteoclast activation marker and oxidative stress parameters including MDA and NO induced by OVX.

conclusionsThe preventive effect of SM was presumably due to its anti-oxidative stress partly via modulation of osteoclast maturation and number. In current study, SM appears to be a promising osteoporosis therapeutic natural product.

Indexed as

PhytotherapySalvia miltiorrhizaAnimalsAntioxidantsBone DensityBone Density Conservation AgentsFemaleHumansMalondialdehydeNitric OxideOsteoclastsOsteoporosis, PostmenopausalOvariectomyOxidative StressPlant ExtractsRadiographyAntioxidantsBone Density Conservation AgentsMalondialdehydeNitric OxidePlant Extracts

Identifiers

PMID22118263
PMCPMC3298536
OpenAlexW2115584570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.